AdvanDx Secures FDA Clearance for Faster Candida Test Protocol | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Molecular diagnostics company AdvanDx announced today that it has received 510(k) clearance from the US Food and Drug Administration for a rapid version of its Yeast Traffic Light PNA FISH test — a method for detecting several species of yeast that can cause hospital-acquired infections.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genetic method to gauge age of ancient samples, genetic polymorphisms in mouse strain, and more.

Two Stanford professors are turning to the online game EteRNA to develop a new way to diagnose tuberculosis.

Lita Nelsen from the Massachusetts Institute of Technology's technology-transfer office is retiring after decades there.

After nine years, the Canadian government is loosening its restrictions on government scientists' ability to speak to the press and public.